
Sign up to save your podcasts
Or
Has the fever broken for the high momentum stocks? Nvidia running out of steam this week, as some other high fliers also pull back. Is this just a bump in the road or the beginning of a summer slowdown? Plus Sarepta’s big surge. The biotech company getting expanded approval from the FDA for its muscular dystrophy drug. What the CEO says is next for the company.
Fast Money Disclaimer
3.9
12371,237 ratings
Has the fever broken for the high momentum stocks? Nvidia running out of steam this week, as some other high fliers also pull back. Is this just a bump in the road or the beginning of a summer slowdown? Plus Sarepta’s big surge. The biotech company getting expanded approval from the FDA for its muscular dystrophy drug. What the CEO says is next for the company.
Fast Money Disclaimer
4,081 Listeners
496 Listeners
238 Listeners
3,179 Listeners
147 Listeners
327 Listeners
67 Listeners
153 Listeners
2,130 Listeners
2,075 Listeners
601 Listeners
545 Listeners
20 Listeners
200 Listeners
408 Listeners
302 Listeners
115 Listeners
807 Listeners
181 Listeners
60 Listeners
156 Listeners
22 Listeners
34 Listeners
16 Listeners
9 Listeners
276 Listeners
15 Listeners